Rayence Co., Ltd.
Financials
Valuation Metrics
Rayence Co., Ltd.'s Market Cap is ₩1380B. At end of 2025 it was ₩863B. Ranked #1071 of 2,421 in KR market (top 44%), #550 of 1,640 on KOSDAQ (top 34%), #35 of 96 in Health Care Equipment & Services (top 36%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 138.04B KRW | KR#1,071/2,421 Sec#35/96 |
| Revenue | 131.69B KRW | KR#1,257/2,421 Sec#20/96 |
| Net Income | 4.14B KRW | KR#1,271/2,421 Sec#41/96 |
| Total Assets | 271.97B KRW | KR#1,097/2,421 Sec#26/96 |
| Net Assets | 242.10B KRW | KR#841/2,421 Sec#20/96 |
| Employees | 230 | KR#992/2,421 Sec#29/96 |
| Value | ||
| P/E | 33.38x | KR#1,337/2,421 Sec#44/96 |
| P/B | 0.57x | KR#929/2,421 Sec#14/96 |
| P/S | 1.05x | KR#1,416/2,421 Sec#30/96 |
| EV/EBITDA | 23.33x | KR#1,082/2,421 Sec#36/96 |
| FCF Yield | 5.18% | KR#840/2,421 Sec#21/96 |
| Profitability | ||
| ROE | 1.71% | KR#1,433/2,421 Sec#48/96 |
| ROA | 1.52% | KR#1,308/2,421 Sec#48/96 |
| Op. Margin | 3.18% | KR#1,225/2,421 Sec#46/96 |
| Revenue Growth | 16.40% | KR#644/2,421 Sec#37/96 |
| Financial Health | ||
| Debt Ratio | 12.34% | KR#195/2,421 Sec#11/96 |
| Total Debt | 774.0M KRW | KR#1,984/2,421 Sec#79/96 |
| FCF | 7.14B KRW | KR#809/2,421 Sec#21/96 |
| Cash | 41.16B KRW | KR#833/2,421 Sec#18/96 |
| Current Ratio | 11.99x | KR#75/2,421 Sec#9/96 |
| Net Debt/EBITDA | -9.65x | KR#45/2,421 Sec#1/96 |
| Dividend | ||
| Div. Yield | 3.59% | KR#504/2,421 Sec#7/96 |
| Div. Growth | 200.00% | KR#46/2,421 Sec#4/96 |
| Performance | ||
| 1Y Return | 41.98% | KR#301/2,421 Sec#5/96 |
| 1M Return | 40.07% | KR#82/2,421 Sec#4/96 |
| From 52W High | -1.65% | KR#3/2,421 Sec#1/96 |
| 1Y MDD | -21.32% | KR#79/2,421 Sec#2/96 |
| Trading | ||
| Volume | 383,669 shares | KR#293/2,421 Sec#10/96 |
| Trading Value | 3.14B KRW | KR#457/2,421 Sec#8/96 |
| Foreign Own. | 3.51% | KR#1,150/2,421 Sec#39/96 |
| Per Share | ||
| EPS | 249 KRW | KR#1,231/2,421 Sec#36/96 |
| BPS | 14,592 KRW | KR#718/2,421 Sec#10/96 |
Company Info
RAYENCE was established in 2011 following the spin-off of its DR business division, and holds several subsidiaries including OSKO MEX and Woori-en Co., Ltd. The company manufactures and sells digital X-ray detectors for medical, dental, veterinary, and industrial applications, and has developed flexible products using CMOS detector technology. RAYENCE leads the market through X-ray Imaging Solutions, expands into the veterinary medical market via its subsidiaries, and broadens its product lineup with new product launches. It is headquartered in Hwaseong-si, Gyeonggi-do.